Qube Research & Technologies Ltd - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 87 filers reported holding UROGEN PHARMA LTD in Q2 2023. The put-call ratio across all filers is 2.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q1 2023$427,008
+185.0%
46,213
+173.6%
0.00%
+100.0%
Q4 2022$149,841
+35.0%
16,893
+27.1%
0.00%0.0%
Q3 2022$111,000
-9.0%
13,289
-11.1%
0.00%0.0%
Q2 2022$122,00014,9430.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 1,252,285$24,156,0007.72%
Horton Capital Management, LLC 375,428$7,242,0006.96%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$56,996,0001.27%
Phoenix Holdings Ltd. 901,979$16,405,0000.69%
SHIKIAR ASSET MANAGEMENT INC 44,550$859,0000.33%
Coastal Bridge Advisors, LLC 37,000$714,0000.22%
Migdal Insurance & Financial Holdings Ltd. 738,302$14,242,0000.20%
Clal Insurance Enterprises Holdings Ltd 529,388$10,212,0000.17%
Vivaldi Capital Management LP 10,000$233,0000.05%
MEITAV INVESTMENT HOUSE LTD 48,407$934,0000.05%
View complete list of UROGEN PHARMA LTD shareholders